Our team

Axys-Network's partners and the back-office experts who support every on-site assignment.

The partners

Eric Latour Eric LatourManaging Director
Jacques Navellou Jacques NavellouManaging Director
Jean-Jacques Chappaz Jean-Jacques ChappazManaging Director
Franck Pavan Franck PavanManaging Director

The back office of experts

Independent consultant? Join our network →
Quality Alain Euzen – Compliance John Orsato – FDA, regulatory affairs Marc Besson – Aseptic practices Patrice Romain – Sterility assurance Jean-Michel Tasserit – Visual inspection
Plant Eric Latour – Industrial projects Marie-Laure Remézy – Pharmaceutical water JP Bovée – HVAC, computerised systems, data integrity Christian Agier – Blow-Fill-Seal Ronan Le Floch – Lean
Technologies Mongi Sakly – Engineering Patrice Romain – Isolators Franck Pavan – Bioprocesses Dr Günther Gapp – Microbiology

International conferences

Franck Pavan: more than 20 talks since 2002

Isolators, highly potent and cytotoxic products, freeze-drying, ATEX, Annex 1: topics presented to A3P, PDA, ISPE and the major European conferences.

Request a presentation
2008 · AwardEuropean Outsourcing Awards – Project Leader Award, Best and Most Improved Facility of the Year (sterile injectables)
2008 · AwardPDA – Wavre (Belgium): Most Valued Speaker of the event
  1. 2025A3P International Congress – Biarritz · Annex 1 and cytotoxic manufacturing (with Fareva)
  2. 2023Pharma Congress – Wiesbaden (Germany) · Disposable isolator: advantages, weaknesses, limits, recycling and sustainability
  3. 2021A3P, Barrier Technologies – Tours · Disposable isolator: advantages, weaknesses, limits, recycling and sustainability
  4. 2019A3P International Congress – Biarritz · Visual inspection: finding the particle is no small matter. Technologies in use and available
  5. 2016SMI – London · Freeze drying potent molecules in explosive environment
  6. 2014World ADC Summit – Frankfurt · Biopharmaceutical manufacturing challenges
    A3P Bioproduction · Technical steps to the production of biopharmaceuticals
  7. 2012PHSS – Dublin · Case study: filling cytotoxic products under isolator
    PDA Pharmaceutical Freeze Drying Technology – Ljubljana · ATEX regulation applied to a manufacturing workshop of high potent injectables
  8. 2010European GMP Conference – Basel · Handling of highly potent compounds: new generation isolators for freeze-dried products with ATEX compliance approach
    Informa – Amsterdam · When to best use disposable and reusable equipment in isolator filling lines
  9. 2009NextLevel Pharma – Vienna · Comparison between in-house production and outsourced alternatives
    Informa – Prague · When to best use disposable and reusable equipment in isolator filling lines
  10. 2008Informa – Dublin · New ATEX regulation applied to a manufacturing workshop of high potent injectables
    PDA – Wavre · New ATEX regulation applied to a manufacturing workshop for high potent freeze-dried injectables
    NextLevel Pharma – Lisbon · Setting up a high potent manufacturing facility
  11. 2007ISPE – Berlin · New generation isolators for freeze-dried products with ATEX compliance approach
    MacEwans – London · Managing challenges of technology transfer: an innovative method
  12. 2006Isolated Parenteral Facilities Users Summit – New Brunswick (USA) · Longest experience in isolator manufacturing: new generation design
  13. 2005Pharmindustry – Cork (Ireland) · High potent drug freeze drying and bursting-proof freeze dryers
  14. 2004A3P International Congress – Biarritz · The environmental challenge of cytotoxic waste in the pharmaceutical industry
  15. 2002A3P International Congress – Tours · Manufacturing highly potent molecules in isolators to an FDA standard